Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-center Study to Evaluate Lot to Lot Consistency, Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults and Compare to the Safety and Immune Response to a Licensed Conjugate Meningococcal ACWY Vaccine

NCT00450437 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT00450437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00450437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-center Study to Evaluate Lot to Lot Consistency, Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults and Compare to the Safety and Immune Response to a Licensed Conjugate Meningococcal ACWY Vaccine
Lead sponsor
Novartis Vaccines
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
January 31, 2008
Enrollment
3,539 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal infections, meningococcal meningitis